Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

37 works

Work: Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase

  1. Syrian Hamster 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Expressed in Escherichia coli: Production of Homogeneous Protein

    Kenneth Frimpong, Bryant G. Darnay, V.W. Rodwell

    Article19934 citations
    ABI

  2. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes

    F. William Studier, Barbara A. Moffatt

    Article19864 citations
    ABI

  3. Biomedical applications of dipeptides and tripeptides

    Sara Santos, Inês M. Torcato, Miguel A. R. B. Castanho

    Review article20124 citations
    ABI

  4. Structure-Based Drug Design: Docking and Scoring

    Romano T. Kroemer

    Review article20074 citations
    ABI

  5. The Natural Products as Hydroxymethylglutaryl-Coa Reductase Inhibitors

    Hayrettin Ozan Gülcan, Serkan Yiğitkan, İlkay Erdoğan Orhan

    Article20184 citations
    ABI

  6. Inhibitor design for <scp>3‐hydroxy‐3‐methyl‐glutaryl‐CoA</scp> reductase enzyme; molecular docking and determination of molecular and electronic properties of ligands by density functional theory method

    Selami Ercan, Ercan Çınar, Cihat Özaydın +2

    Article20204 citations
    ABI

  7. Low High-Density Lipoprotein Cholesterol and Increased Cardiovascular Disease Risk: An Analysis of Statin Clinical Trials

    Prakash Deedwania, Vibhuti Singh, Michael H. Davidson

    Article20093 citations
    ABI

  8. Hypercholesterolemia As a Risk Factor for Cardiovascular Disease: Current Controversial Therapeutic Management

    Arturo Zárate, Leticia Manuel‐Apolinar, Renata Saucedo +2

    Review article20163 citations
    ABI

  9. Molecular aspects of hypercholesterolemia treatment: current perspectives and hopes

    Najmeh Ahangari, Majid Ghayour‐Mobarhan, Amirhossein Sahebkar +1

    Review article20183 citations
    ABI

  10. Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million Patients

    L. Masana, Alberto Zamora, Núria Plana +9

    Article20193 citations
    ABI

  11. Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total Mortality

    Patricia R. Hebert, J. Michael Gaziano, Ki Sau Chan +1

    Article19982 citations
    ABI

  12. Untitled

    Other1 citations
    ABI